Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myeloma
Antibody-drug conjugates (ADC) represent a distinct family of chemoimmunotherapy agents. ADCs are composed of monoclonal antibodies conjugated to cytotoxic payloads via specialized chemical linkers. ADCs there...
Source: Journal of Hematology and Oncology - Category: Hematology Authors: Bo Yu and Delong Liu Tags: Review Source Type: research